The expression of CXCL10 has been reported in several forms of epilepsy and the levels of CXCL10 in blood or cerebrospinal fluid (CSF) could be used as biomarkers of the progression of the disease [39,40,78,79,80]. Here, CXCL10 is linked to epilepsy.